Epic Build / Desired Build Test Compendium
Welcome to the new Northwell Health Labs Epic Build / Desired Build Test Directory! Please email ClinicalLabInformatics@northwell.edu with any typos, corrections or issues.

OnkoSight Myeloid Seq

Desired Epic Build * = editable field  

Cerner Primary Mnemonic: OnkoSight Myeloid Seq
PDM 1659893
Informatics - WorkgroupMolecular-send outs
Synonyms *OnkoMyelo
Display Name *OnkoSight Myeloid Seq
Specimen Sources (combined Order Entry and Specimen Navigator) *
Bone Marrow
Specimen Types (combined Order Entry and Specimen Navigator) *
Tissue
Blood
Bone Marrow
Body Fluids (types sent through AOEs)
Specimen Navigator Specimen Types
Aspirate
Specimen Navigator Specimen Sources
Isthmus
Left
Nasal
No Laterality
Right
Total
Abdomen/Peritoneum
Abscess
Adrenal
Amniotic Sac
Anus
Appendix
Axilla
Bile Duct
Bone
Bone Marrow
Brain
Breast
Bronchial
Buccal
Colon
Duodenum
Ear
Esophagus
Extranodal Lymphoid
Eye
Fallopian Tube
Gallbladder
Gingiva
Ileum
Jejunum
Joint
Kidney
Larynx
Liver
Lung
Lymph Node
Mediastinum
Meninges/Dura
Misc
Muscle
Nasopharynx
Nipple
Nose
Oropharynx/Throat
Ovary
Palate
Pancreas
Pancreatic Duct
Parathyroid
Paratubal Cyst
Pelvic
Penis
Pericardium
Pharynx
Pleura
Prostate
Rectum
Retroperitoneum
Salivary Gland
Sinus
Skin
Soft Tissue
Spleen
Stomach
Testis
Thymus
Thyroid
Tongue
Tonsil
Trachea
Uterus
Vagina
Vas Defe
Specimen Navigator Short NameOnkosight NGS Myeloid Malignancies
Ordering info (EPIC SmartText)Tumor sequencing by NGS detecting mutations in 50 genes associated with myeloid malignancies. Mutations often have prognostic significance, may confer resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.
IP Orderable (inpatient) Yes
OP Orderable (outpatient) Yes
AOEs *

AOE PDM AOE Display AOE Description Prompt
AOE00021 Diagnosis Under Consideration: Diagnosis Under Consideration: X
AOE00022 Anatomic Location of Primary Lesion : Anatomic Location of Primary Lesion : X
AOE00023 HemPath Source HemPath Source X
AOE00024 Initial Diagnosis or Relapse Initial Diagnosis or Relapse X
AOE00025 Number of Prior Treatment Number of Prior Treatment X
AOE00026 Prior Treatment Prior Treatment X
AOE00027 TNM Staging Clinical TNM Staging Clinical X
AP AOEs
Special History No
Build Comments
Filter *genetics
Cerner Site RestrictBio Reference Laboratory
BioReference Health LLC
Northwell Health Laboratories
Cerner Results

Result Desc Result display Result PDM
MYE Interpretation Summary MYE Interp 1659893C
MYE Detailed Genetic Interpretation 1 MYE Gen 1 1659893D
MYE References 2 MYE REF 2 1659893K
Allele Frequencies MYE FREQ 1659893N
MYE Therapeutic Associations and Prognostic Associations MYE Prog 1659893B
MYE Detailed Genetic Interpretation 2 MYE Gen 2 1659893E
MYE References 1 MYE REF 1 1659893J
Addendum MYE ADD 1659893M
OnkoSight Advanced NGS Myeloid Panel OnkoSight Myeloid 1659893A
MYE Clinical Trials 1 MYE CT 1 1659893F
MYE Technical Summary MYE TECH 1659893H
MYE Report Footer MYE Report1 1659893L
MYE Methods (BRI) MYE Meth 1659893I
MYE Clinical Trials 2 MYE CT 2 1659893G

Actual Epic Build 3/11/2025

PROCEDURE ID 111548
PDM 1659893
ORDER DISPLAY NAME OnkoSight Myeloid Seq
PROCEDURE NAME ONKOSIGHT NGS MYELOID MALIGNANCIES PANEL
PROCEDURE MASTER NUMBER LAB10522
SHORT PROCEDURE NAME ONKOSIGHT NGS MYELOID MALIGNANCIES PANEL
CATEGORY CODE 1.0
CATEGORY CODE RECORD NAME LAB BLOOD ORDERABLES
SYNONYMS ONKOMYELO
CLINICALLY ACTIVE Yes
ORDERABLE Yes
PERFORMABLE Yes
FILTER GENOMICS Generic Genomics Procedure
REFERENCE LINK URL https://labs.northwell.edu/epic/test/111548
ORDERING INSTRUCTIONS
DEFAULT SPECIMEN TYPE Blood
SPECIMEN TYPE PICK LIST Bone Marrow
Blood
Aspirate
SPECIMEN TYPE LIST
OP SPECIMEN TYPE LIST
SPECIMEN SOURCE PICK LIST Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
Bone Marrow Aspirate
Bone Marrow
SPECIMEN SOURCE DEFAULT - MALE Blood, Venous
SPECIMEN SOURCE DEFAULT - FEMALE Blood, Venous
SPECIMEN SOURCE LIST
OP SPECIMEN SOURCE LIST
IP LAB TEST COMPONENTS FOR REPORT ONKOMYSEQ
MYEPROG
MYEINTERP
MYEGENINT1
MYEGENINT2
MYECT1
MYECT2
MYETECH
MYEMETHOD
MYEREF1
MYEREF2
MYEREPORT
MYE
OP LAB TEST COMPONENTS FOR REPORT ONKOMYSEQ
MYEPROG
MYEINTERP
MYEGENINT1
MYEGENINT2
MYECT1
MYECT2
MYETECH
MYEMETHOD
MYEREF1
MYEREF2
MYEREPORT
MYE
ORDER QUESTIONS ["3046000078", "3046000079", "3046000080", "3046000081", "3046000082", "3046000083", "3046000084", "3045300170", "3045300171", "3045300173"]
ORDER QUESTIONS RECORD NAME NH IP DX UNDER CONS
NH IP ANATOMIC LOCATION OF PRIMARY LESION
NH IP HEMPATH SOURCE
NH IP INITIAL DX OR RELAPSE
NH IP NUMBER OF PRIOR TREATMENT
NH IP PRIOR TREATMENT
NH IP TNM STAGING CLINICAL
NH IP HOME COLLECT DATE
NH IP HOME COLLECT DAYS
NH IP HOME COLLECT MEDICALLY NECESSARY
INPATIENT ORDER QUESTIONS ["3046000078", "3046000079", "3046000080", "3046000081", "3046000082", "3046000083", "3046000084"]
INPATIENT ORDER QUESTIONS RECORD NAME NH IP DX UNDER CONS
NH IP ANATOMIC LOCATION OF PRIMARY LESION
NH IP HEMPATH SOURCE
NH IP INITIAL DX OR RELAPSE
NH IP NUMBER OF PRIOR TREATMENT
NH IP PRIOR TREATMENT
NH IP TNM STAGING CLINICAL
ORDER SPECIFIC QUESTION OVERRIDE Yes
INPATIENT QUESTION OVERRIDE
LOCATION RESTRICT LIST IP
LOCATION RESTRICT LIST IP RECORD NAME
LOCATION RESTRICT LIST INCLUDE IP
LOCATION RESTRICT LIST OP
LOCATION RESTRICT LIST OP RECORD NAME
LOCATION RESTRICT LIST INCLUDES OP
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP SPECIMEN SOURCE Blood, Venous
Blood, Central Line
Blood, Arterial
Blood, Capillary
EDP OP SPECIMEN SOURCE
EDP IP SPECIMEN TYPE Blood
EDP OP SPECIMEN TYPE
DERIVED EDP IP BUTTONS S Blood, Central Line
Blood, Arterial
Blood, Capillary
Blood, Venous
DERIVED EDP IP BUTTONS T Blood
DERIVED EDP OP BUTTONS S
DERIVED EDP OP BUTTONS T
IP ORDERABLE 1
OP ORDERABLE 1
STANDARD LAB COMPONENTS
STANDARD LAB COMPONENTS RECORD NAME
COMPONENT DATA REQUIREMENT
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3045300170 NH IP HOME COLLECT DATE Start Date Date Yes
3045300171 NH IP HOME COLLECT DAYS Days Custom List Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Yes
3045300173 NH IP HOME COLLECT MEDICALLY NECESSARY Medically Necessary? Yes/No Yes
3046000078 NH IP DX UNDER CONS Diagnosis Under Consideration: Free Text No
3046000079 NH IP ANATOMIC LOCATION OF PRIMARY LESION Anatomic Location of Primary Lesion: Free Text No
3046000080 NH IP HEMPATH SOURCE HemPath Source Free Text No
3046000081 NH IP INITIAL DX OR RELAPSE Initial Diagnosis or Relapse Free Text No
3046000082 NH IP NUMBER OF PRIOR TREATMENT Number of Prior Treatment Free Text No
3046000083 NH IP PRIOR TREATMENT Prior Treatment Free Text No
3046000084 NH IP TNM STAGING CLINICAL TNM Staging Clinical: Free Text No
EPIC IP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3046000078 NH IP DX UNDER CONS Diagnosis Under Consideration: Free Text No
3046000079 NH IP ANATOMIC LOCATION OF PRIMARY LESION Anatomic Location of Primary Lesion: Free Text No
3046000080 NH IP HEMPATH SOURCE HemPath Source Free Text No
3046000081 NH IP INITIAL DX OR RELAPSE Initial Diagnosis or Relapse Free Text No
3046000082 NH IP NUMBER OF PRIOR TREATMENT Number of Prior Treatment Free Text No
3046000083 NH IP PRIOR TREATMENT Prior Treatment Free Text No
3046000084 NH IP TNM STAGING CLINICAL TNM Staging Clinical: Free Text No
EPIC Components (results - crosswalked through Cerner)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047803679.0 MYE INTERPRETATION SUMMARY MYEINTERP MYE INTERPRETATION SUMMARY 1659893C
3047803677.0 MYE DETAILED GENETIC INTERPRETATION 1 MYEGENINT1 MYE DETAILED GENETIC INTERPRETATION 1 1659893D
3047803683.0 MYE REFERENCES 2 MYEREF2 MYE REFERENCES 2 1659893K
3047803674.0 MYE ALLELE FREQUENCIES MYE MYE ALLELE FREQUENCIES 1659893N
3047803681.0 MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS MYEPROG MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS 1659893B
3047803678.0 MYE DETAILED GENETIC INTERPRETATION 2 MYEGENINT2 MYE DETAILED GENETIC INTERPRETATION 2 1659893E
3047803682.0 MYE REFERENCES 1 MYEREF1 MYE REFERENCES 1 1659893J
3047803673.0 MYE ADDENDUM MYE MYE ADDENDUM 1659893M
3046000187.0 ONKOSIGHT MYELOID SEQUENCE ONKOMYSEQ ONKO MYELO SEQ 1659893A
3047803675.0 MYE CLINICAL TRIALS 1 MYECT1 MYE CLINICAL TRIALS 1 1659893F
3047803685.0 MYE TECHNICAL SUMMARY MYETECH MYE TECHNICAL SUMMARY 1659893H
3047803684.0 MYE REPORT FOOTER MYEREPORT MYE REPORT FOOTER 1659893L
3047803680.0 MYE METHODS MYEMETHOD MYE METHODS 1659893I
3047803676.0 MYE CLINICAL TRIALS 2 MYECT2 MYE CLINICAL TRIALS 2 1659893G